Madrigal Makes Potential $2B+ Wager for CSPC’s GLP-1 Capsule
Madrigal Prescribed drugs is trying to China to deepen its metabolic experience, partnering with Shijiazhuang-based CSPC Pharmaceutical Group Restricted to...
Pharmaceutical Updates
South Korea emerges as 2025 licensing hub with 113% development and billion-dollar offers
South Korea’s biopharmaceutical sector has seen a surge in innovator drug licensing agreements, reaching a complete deal worth of $7.86bn...
Pharma tariffs set at 15% in European Union commerce deal
WASHINGTON — President Trump’s tariffs on prescription drugs coming from the European Union can be set at 15% and won't...
GSK Bets Up To $12B for Multi-Program Most cancers Pact With Hengrui
In one of many greatest licensing pacts signed up to now this yr, GSK has put $12 billion on the...
UK-India $4.8bn FTA poised to learn medtech and pharma
The settlement means India will regularly section down import duties on UK medical gadgets, rendering British medical gadget exports extra...
Sarepta, Eli Lilly, SSRI results, NIH, Bristol
Wish to keep on high of the science and politics driving biotech immediately? Join to get our biotech publication in your inbox....
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
Eli Lilly is partnering with the Bay Space–based mostly Gate Bioscience in a deal price as much as $856 million...
Pharma braces for important French drug pricing reforms pending CEPS’s report
Rising budgetary stress is a central theme in France because the nation prepares for the publication of the federal government’s...
STAT+: Tessera cuts jobs amid monetary challenges
Wish to keep on prime of the science and politics driving biotech as we speak? Join to get our biotech e-newsletter in...
GSK’s Comeback for Blenrep on Pause as FDA Delays Resolution
The FDA has pushed again its goal determination date for GSK’s antibody-drug conjugate Blenrep, being proposed for the second-line therapy...
UK enacts regulation to decentralise manufacture of personalised therapies
The brand new laws will scale back the time it takes for sufferers to obtain these therapies from months to...
New CDER director at FDA, how rescissions have an effect on well being coverage
You’re studying the online version of D.C. Prognosis, STAT’s twice-weekly e-newsletter in regards to the politics and coverage of well...
Sophie Kornowski: From Drugs Style-Tester to Information-Pushed Dealmaker
Sophie Kornowski most likely is aware of greater than another CEO {that a} spoonful of sugar helps the medication go...
Life sciences VC Omega Funds closes $647m funding spherical
Based on Omega Funds, it has raised $2.5bn since launching in 2004. Picture credit score: Sutthiphong Chandaeng through Shutterstock.com. Life...
GSK faces most cancers setback; third Sarepta gene remedy affected person dies
And so, one other working week will quickly draw to an in depth. Not a second too quickly, sure? That...
